Both in Pharmaceuticals
Spero Therapeutics vs XBiotech
Over the past year SPRO returned −54.6% and XBIT returned −16.2%; their daily moves had a correlation of 0.12.
SPRO −54.6% XBIT −16.2%Growth of $1, one year, split-adjusted
| Metric | SPRO | XBIT |
|---|---|---|
| Price | $1.08 | $1.92 |
| Market cap | $62.9M | $58.5M |
| Today | +3.85% | −3.52% |
| 1 month | −9.2% | −11.1% |
| 6 months | −57.3% | −24.7% |
| Year to date | −53.6% | −19.7% |
| 1 year | −54.6% | −16.2% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 8.5× | — |
| Price / sales | 1.3× | — |
| Net cash | $50.7M | $109.5M |
| Dividend yield | — | — |
| Volatility (60d) | 59.3% | 36.4% |
| Short % of float | 2.0% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).